Form 4: Replimune Group Chief Medical Officer Sells Shares to Cover Tax Obligations

Konstantinos Xynos, Chief Medical Officer of Replimune Group, sold 7,952 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On May 20, 2025, Konstantinos Xynos, the Chief Medical Officer of Replimune Group, Inc., sold 7,952 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the partial vesting of his restricted stock units (RSUs).
• The shares were sold at a weighted average price of $8.06, with individual transactions ranging from $8.05 to $8.80 per share.
• Following the transaction, Xynos directly owns 146,933 shares of Replimune Group, Inc.
• The sale was conducted according to a pre-arranged 'sell to cover' provision in the RSU award agreements, not representing a discretionary sale.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, which is a common practice and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.

Key Dates

Keywords

Replimune Group, Konstantinos Xynos, Chief Medical Officer, Stock Sale, Form 4, Tax Withholding, Restricted Stock Units, REPL